Skip to main content
Caplight Logo









Sarcura

Sarcura

Private
KlosterneuburgHealthcare & Life Scienceshttps://sarcura.com

Last Round

Grant

Mar 5, 2024

Total Funding Raised

$13.92M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Sarcura is a biotech company that develops a machine platform for the large-scale, industrial manufacturing of personalized cell therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Medical Devices, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

cell therapy manufacturingmicrofluidicsbiomanufacturingCAR-Tlab-on-a-chipbioprocessingautomated cell therapysilicon photonicsCDMOcontract development and manufacturing organizationsingle-use technologypersonalized medicinebiotech equipmentPATprocess analytical technology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sarcura Comparables

Compare Sarcura with similar companies based on industry and business-model similarity.

Sarcura comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Astraveus
89%
Limula
88%
MFX
81%

Sarcura Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 5, 2024
GrantJun 1, 2023
SeedNov 17, 2022
GrantMar 1, 2021
SeedNov 19, 2020

Key People

Founding team and executive leadership

Erwin Gorjup

Chief Scientific Officer & Co-Founder

Founding Team

Daniela Buchmayr

CEO Co-Founder

Founding Team

Sarcura Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 389% MoM, reaching 2.7K.

  • Jul 25, 2026

    Monthly visitors grew 367% MoM, from 116 to 542.

Sarcura Filings

Explore SEC and related filing metadata, where available.

Sarcura filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Sarcura's valuation, stock price, and market status.

Is Sarcura a public or private company?

Sarcura is a private company.

What is the current stock price of Sarcura?

Sarcura is a private company with no public stock price. No recent secondary market data is available.

How much is Sarcura worth (valuation)?

Valuation information for Sarcura is not publicly available.

Can I buy Sarcura stock?

Sarcura shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Sarcura's last funding round?

Sarcura's most recent funding round was Grant on March 5, 2024.

Who are the main investors in Sarcura?

Key investors in Sarcura include IST cube.

Will Sarcura IPO soon?

No public IPO plans have been announced for Sarcura.

How can I track Sarcura secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sarcura's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersKlosterneuburg
Employee Range8
Year Founded2019
Last FundingMar 5, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?